Posted in | News | Materials Processing | Business

MIM Completes Sale of German Zinc Smelter

Dec 9 2002

Related Stories

The sale of Mt Isa Mines (MIM) German zinc smelting business MHD, announced on October 28 has been concluded. MHD was sold to Sudamin Investment GmbH. Sudamin is a subsidiary of Safeguard International LP, based in the USA.

MHD comprises a zinc smelter, lead smelter and zinc refinery located in Duisburg, Germany.

Sudamin intends to restructure MHD to ensure its long term survival. Aside from re-organising the business, they intend to invest in several items of capital equipment as well as adding to its secondary processing capacity.

MIM are pleased with the outcome as they had been looking for a way to divest this non-core business for some time and the sale presented a better opportunity than closing the business.

For more information on zinc, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback